Dr. Matthew Potthoff, PhD, an Assistant Professor in the Department of Pharmacology, has been awarded a National Institute of Health (NIH) R01 Research Grant for his project, titled “Regulation of Carbohydrate Metabolism by FGF21 Action on Brown Adipose Tissue.”  The goal of this research is to determine the mechanism for the glucose lowering effects of the endocrine hormone fibroblast growth factor 21 (FGF21).  FGF21 is currently being pursued as a potential therapeutic for the treatment of obesity and diabetes.